ImmunityBio, Inc. IBRX Proceeds From Warrant Exercises
Proceeds From Warrant Exercises at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromWarrantExercises.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s proceeds from warrant exercises.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s proceeds from warrant exercises?
- ImmunityBio, Inc. (IBRX) reported proceeds from warrant exercises of $53.54M in Q1 2026.
- What does proceeds from warrant exercises mean?
- Cash received by the company when holders of warrants choose to exercise their rights to purchase company stock. This represents a non-dilutive source of capital that occurs when the stock price exceeds the warrant strike price.